2019
DOI: 10.1021/acs.oprd.9b00373
|View full text |Cite
|
Sign up to set email alerts
|

A Short Review of Synthetic Routes for the Antiepileptic Drug (R)-Lacosamide

Abstract: The disease epilepsy affects people of all ages and is due to a chronic neurological disorder in the brain. According to a report by the World Health Organization, epilepsy is one of the most common global neurological diseases. (R)-Lacosamide (Vimpat) was introduced by UCB Pharma in 2008 for the treatment of partial-onset seizures in patients suffering from epilepsy. This review summarizes all of the available synthetic strategies reported for (R)-lacosamide, which will help medicinal chemists in the further … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
12
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 9 publications
(15 citation statements)
references
References 40 publications
2
12
0
1
Order By: Relevance
“…These initial results, in parallel with the corroborating observations made in the literature, 9 allowed subsequent route design to be focused into the following key areas:…”
Section: ■ Results and Discussionsupporting
confidence: 62%
“…These initial results, in parallel with the corroborating observations made in the literature, 9 allowed subsequent route design to be focused into the following key areas:…”
Section: ■ Results and Discussionsupporting
confidence: 62%
“…One of such compounds is the antiepileptic agent lacosamide (Scheme ). First synthesized in 1996, lacosamide and structurally related compounds show an important anticonvulsant activity for which they have recently received much attention . Despite such an interest, most of the synthetic approaches reported up to now rely on the appropriate treatment of d ‐serine or other starting materials from the chiral pool .…”
Section: Resultsmentioning
confidence: 99%
“…First synthesized in 1996, lacosamide [12] and structurally relatedc ompoundss how an important anticonvulsant activity [18] for which they have recently received much attention. [13] Despite such an interest, most of the synthetic approaches reported up to now rely on the appropriate treatment of d-serine or others tartingm aterials from the chiral pool. [18,19] Alternatively,afew syntheses involve kinetic resolution steps [20] or are based on asymmetric reactions applied to substrates containing the required carbon backbone.…”
Section: Retrosynthetic Analysismentioning
confidence: 99%
See 1 more Smart Citation
“…A lacosamida pode ser obtida através de diferentes metodologias, recentemente revistas na literatura [51]. Para além da abordagem multicomponente descrita no Esquema 3, escolhemos o exemplo de S. Stecko como uma abordagem de síntese passo--a-passo [52], já que neste exemplo é reportada uma descrição cuidada do procedimento experi-Esquema 9 -Síntese de praziquantel usando uma reação de Ugi de quatro componentes [49].…”
Section: Sustentabilidade E Rmc: O Exemplo Da Lacosamidaunclassified